Prestige Consumer Healthcare
PBH
#4654
Rank
$2.28 B
Marketcap
$48.23
Share price
0.75%
Change (1 day)
-20.93%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2026 (TTM): $3.59

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is $3.59. In 2025 the company made an earnings per share (EPS) of $3.81 a decrease over its 2024 EPS that were of $4.30.

EPS history for Prestige Consumer Healthcare from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)$3.59-5.77%
2025$3.81-11.4%
2024$4.30-367.08%
2023-$1.61-138.33%
2022$4.2011.7%
2021$3.7613.6%
2020$3.31-651.67%
2019-$0.60-148.78%
2018$1.23-83.29%
2017$7.36437.23%
2016$1.37-34.13%
2015$2.0852.94%
2014$1.36-8.11%
2013$1.48
2011$0.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$8.73 143.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
$6.76 88.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$6.66 85.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$0.76-78.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$3.12-13.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
$6.18 72.14%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
$2.31-35.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$3.20-10.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
-$29.62-925.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
$1.22-66.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel